Eradication therapy for Helicobacter pylori is recommended in a number of clinical
conditions. In this article, we discuss the epidemiology and cellular mechanisms that result …

Background Antimicrobial resistance of Helicobacter pylori (H. pylori) affects the efficacy of
eradication therapy. The aim of this study was to estimate the prevalence of primary and …

Aims To describe the characteristics of Helicobacter pylori (H. pylori) antibiotic resistance in
clinical isolates from four populations. Methods In total, 1463 H. pylori strains were …

Infection with Helicobacter pylori remains a major healthcare burden, with persistently high
prevalence rates, especially in less-developed countries. H. pylori infection is causally …

Objective: The aim of the present study was to assess the primary and secondary resistance
of Helicobacter pylori strains to clarithromycin, amoxicillin, furazolidone, tetracycline, and …

Abstract Background and Aim: Clarithromycin‐based triple therapy has been commonly
applied as the first‐line therapy for Helicobacter pylori eradication. Levofloxacin could serve …

Metodos. Las muestras fueron biopsias gastricas procedentes de pacientes pediatricos
sintomaticos. H. pylori fue cultivado acorde con los estandares de los procedimientos …

Abstract Background Primary Helicobacter pylori (H. pylori) infection occurs predominantly
in childhood. Antimicrobial resistance is the leading cause for H. pylori eradication failure …

Antibiotic resistance is a key factor in the failure of Helicobacter pylori eradication therapy,
yet few sentinel schemes exist to monitor trends in resistance at local, national or …

Helicobacter pylori infection is more common in Alaska Native persons than in the general
US population, with seroprevalence to H. pylori approaching 75%. Previous studies in …